Seoul, South Korea

Seoktaek Lee

This inventor holds 3 USPTO granted patents. Top assignees: Idience Co., Ltd., Il Dong Pharmaceutical Co., Ltd.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seoktaek Lee. Retrieved from https://idiyas.com/inventor/seoktaek-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Seoktaek Lee: A Pioneer in Pharmaceutical Chemistry

Introduction

Seoktaek Lee is a notable inventor based in Seoul, South Korea, recognized for his contributions to pharmaceutical chemistry. With a total of three patents to his name, he has made significant advancements in the preparation of phthalazinone derivatives, which are crucial in the development of various pharmaceutical compounds.

Latest Patents

One of his latest patents is titled "Process for preparing a phthalazinone derivative and intermediates thereof." This application outlines a method for preparing 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one, along with its pharmaceutically acceptable salts. The method ensures high purity and yield of the compound, which is essential for pharmaceutical applications. Another significant patent is "Crystalline forms of phthalazinone compound," which provides details on the crystalline forms of 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one hydrochloride. This patent also includes methods for preparing these forms and pharmaceutical compositions that incorporate them.

Career Highlights

Seoktaek Lee has worked with prominent companies in the pharmaceutical industry,

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…